ScoreWhy is Tibet Duo Rui Pharmaceutical Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of -15.87% and Operating profit at -376.81% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 9.99% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -15.87% and Operating profit at -376.81% over the last 5 years
3
The company has declared negative results for the last 13 consecutive quarters
- INTEREST(HY) At CNY 5.68 MM has Grown at 98.65%
- OPERATING CASH FLOW(Y) Lowest at CNY -65.27 MM
- ROCE(HY) Lowest at -18.97%
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 200.00%, its profits have fallen by -2999.8%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Tibet Duo Rui Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Tibet Duo Rui Pharmaceutical Co., Ltd.
200.0%
4.05
75.22%
China Shanghai Composite
17.07%
1.07
14.99%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-15.87%
EBIT Growth (5y)
-376.81%
EBIT to Interest (avg)
51.69
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0.25
Sales to Capital Employed (avg)
0.28
Tax Ratio
0.84%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
29.23%
ROE (avg)
9.99%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.06
EV to EBIT
-25.38
EV to EBITDA
-36.80
EV to Capital Employed
4.03
EV to Sales
17.65
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-15.88%
ROE (Latest)
-21.65%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
NET PROFIT(HY)
Higher at CNY -64.13 MM
-44What is not working for the Company
INTEREST(HY)
At CNY 5.68 MM has Grown at 98.65%
OPERATING CASH FLOW(Y)
Lowest at CNY -65.27 MM
ROCE(HY)
Lowest at -18.97%
DEBT-EQUITY RATIO
(HY)
Highest at 6.28 %
PRE-TAX PROFIT(Q)
At CNY -52.81 MM has Fallen at -51.47%
NET PROFIT(Q)
At CNY -37.22 MM has Fallen at -45.8%
RAW MATERIAL COST(Y)
Grown by 83.87% (YoY
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.6 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.77 times
NET SALES(Q)
Lowest at CNY 30.43 MM
OPERATING PROFIT(Q)
Lowest at CNY -49.75 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -163.52 %
Here's what is not working for Tibet Duo Rui Pharmaceutical Co., Ltd.
Interest
At CNY 5.68 MM has Grown at 98.65%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
At CNY 30.43 MM has Fallen at -38.17%
over average net sales of the previous four periods of CNY 49.21 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Operating Cash Flow
Lowest at CNY -65.27 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Pre-Tax Profit
At CNY -52.81 MM has Fallen at -51.47%
over average net sales of the previous four periods of CNY -34.87 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -37.22 MM has Fallen at -45.8%
over average net sales of the previous four periods of CNY -25.53 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Debt-Equity Ratio
Highest at 6.28 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Net Sales
Lowest at CNY 30.43 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Operating Profit
Lowest at CNY -49.75 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at -163.52 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Inventory Turnover Ratio
Lowest at 2.6 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 1.77 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 83.87% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
